Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.

PubMed  PubMed Central  Google Scholar 

Borbath I, Garcia-Carbonero R, Bikmukhametov D, Jimenez-Fonseca P, Castaño A, Barkmanova J, et al. The European neuroendocrine tumour society registry, a tool to assess the prognosis of neuroendocrine neoplasms. Eur J Cancer. 2022;168:80–90.

CAS  PubMed  Google Scholar 

Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the north american neuroendocrine tumor society. Pancreas. 2017;46(6):715–31.

PubMed  PubMed Central  Google Scholar 

Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, et al. The North American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(1):1–33.

PubMed  PubMed Central  Google Scholar 

Kos-Kudła B, Castaño JP, Denecke T, Grande E, Kjaer A, Koumarianou A, et al. European neuroendocrine tumour society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol. 2023;35(12):e13343.

PubMed  Google Scholar 

Hofland J, Falconi M, Christ E, Castaño JP, Faggiano A, Lamarca A, et al. European neuroendocrine tumor society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023;35(8):e13318.

CAS  PubMed  Google Scholar 

Lamarca A, Bartsch DK, Caplin M, Kos-Kudla B, Kjaer A, Partelli S, et al. European neuroendocrine tumor society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours. J Neuroendocrinol. 2024;36(9):e13423.

CAS  PubMed  Google Scholar 

Kaltsas G, Walter T, Knigge U, Toumpanakis C, Santos AP, Begum N, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET). J Neuroendocrinol. 2023;35(10):e13332.

CAS  PubMed  Google Scholar 

Rinke A, Ambrosini V, Dromain C, Garcia-Carbonero R, Haji A, Koumarianou A, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours. J Neuroendocrinol. 2023;35(6):e13309.

CAS  PubMed  Google Scholar 

Panzuto F, Ramage J, Pritchard DM, van Velthuysen M-LF, Schrader J, Begum N, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3. J Neuroendocrinol. 2023;35(8):e13306.

CAS  PubMed  Google Scholar 

Albers MB, Almquist M, Bergenfelz A, Nordenström E. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias. Langenbeck’s Archives Surg. 2020;405(2):137–43.

Google Scholar 

Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255–65.

CAS  PubMed  Google Scholar 

Assi HA, Mukherjee S, Kunz PL, Machiorlatti M, Vesely S, Pareek V, et al. Surgery versus surveillance for well-differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11-year analysis of the national cancer database. Oncologist. 2020;25(2):e276-83.

CAS  PubMed  Google Scholar 

Partelli S, Massironi S, Zerbi A, Niccoli P, Kwon W, Landoni L, et al. Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. Br J Surg. 2022;109(12):1186–90.

PubMed  PubMed Central  Google Scholar 

Heidsma CM, Engelsman AF, van Dieren S, Stommel MWJ, de Hingh I, Vriens M, et al. Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA). Br J Surg. 2021;108(8):888–91.

CAS  PubMed  PubMed Central  Google Scholar 

Chivukula SV, Tierney JF, Hertl M, Poirier J, Keutgen XM. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: are we over- or undertreating patients? Surgery. 2020;167(1):180–6.

PubMed  Google Scholar 

Nießen A, Bechtiger FA, Hinz U, Lewosinska M, Billmann F, Hackert T, et al. Enucleation is a feasible procedure for well-differentiated pNEN-A matched pair analysis. Cancers (Basel). 2022;14(10).

Mehrabi A, Fischer L, Hafezi M, Dirlewanger A, Grenacher L, Diener MK, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014;43(5):675–86.

PubMed  Google Scholar 

de Carbonnières A, Challine A, Cottereau AS, Coriat R, Soyer P, Abou Ali E, et al. Surgical management of insulinoma over three decades. HPB (Oxford). 2021;23(12):1799–806.

PubMed  Google Scholar 

Beane JD, Borrebach JD, Billderback A, Onuma AE, Adam MA, Zureikat AH, et al. Small pancreatic neuroendocrine tumors: resect or enucleate? Am J Surg. 2021;222(1):29–34.

PubMed  Google Scholar 

Hüttner FJ, Koessler-Ebs J, Hackert T, Ulrich A, Büchler MW, Diener MK. Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg. 2015;102(9):1026–36.

PubMed  Google Scholar 

Zhou Y, Zhao M, Wu L, Ye F, Si X. Short- and long-term outcomes after enucleation of pancreatic tumors: an evidence-based assessment. Pancreatology. 2016;16(6):1092–8.

PubMed  Google Scholar 

Nießen A, Schimmack S, Lewosinska M, Hinz U, Bechtiger FA, Hackert T, et al. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms. Surgery. 2022;172(6):1791–9.

PubMed  Google Scholar 

Zhang Z, Liu M, Ji S, Luo G, Xu W, Liu W, et al. Prognostic value and clinical predictors of Lymph Node metastases in pancreatic neuroendocrine tumors. Pancreas. 2020;49(3):381–6.

CAS  PubMed  Google Scholar 

Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, et al. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg. 2013;148(10):932–9.

PubMed  Google Scholar 

Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008;247(3):490–500.

PubMed  Google Scholar 

Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey J-N, Adams DB, et al. Prognostic value of Lymph Node Status and Extent of Lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg. 2016;20(12):1966–74.

PubMed  Google Scholar 

Giulianotti PC, Coratti A, Angelini M, Sbrana F, Cecconi S, Balestracci T, et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg. 2003;138(7):777–84.

PubMed  Google Scholar 

Joyce D, Morris-Stiff G, Falk GA, El-Hayek K, Chalikonda S, Walsh RM. Robotic surgery of the pancreas. World J Gastroenterol. 2014;20(40):14726–32.

PubMed  PubMed Central  Google Scholar 

Klotz R, Mihaljevic AL, Kulu Y, Sander A, Klose C, Behnisch R, et al. Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial. Lancet Reg Health Eur. 2024;39:100864.

PubMed  PubMed Central  Google Scholar 

de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, et al. Minimally invasive Versus Open Distal pancreatectomy (LEOPARD): a Multicenter patient-blinded Randomized Controlled Trial. Ann Surg. 2019;269(1):2–9.

PubMed  Google Scholar 

Korrel M, Jones LR, van Hilst J, Balzano G, Björnsson B, Boggi U, et al. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Lancet Reg Health Eur. 2023;31:100673.

PubMed  PubMed Central  Google Scholar 

Li P, Zhang H, Chen L, Liu T, Dai M. Robotic versus laparoscopic distal pancreatectomy on perioperative outcomes: a systematic review and meta-analysis. Updates Surg. 2023;75(1):7–21.

PubMed  Google Scholar 

Partelli S, Andreasi V, Rancoita PMV, Perez-Sanchez E, Muffatti F, Balzano G, et al. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting. Surg Endosc. 2021;35(1):165–73.

PubMed  Google Scholar 

Zheng J, Pulvirenti A, Javed AA, Michelakos T, Paniccia A, Lee KK, et al. J Am Coll Surg. 2022;235(2):315–30.

Pavone M, Seeliger B, Teodorico E, Goglia M, Taliento C, Bizzarri N, et al. Ultrasound-guided robotic surgical procedures: a systematic review. Surg Endosc. 2024;38(5):2359–70.

PubMed  PubMed Central  Google Scholar 

Paiella S, De Pastena M, Landoni L, Esposito A, Casetti L, Miotto M, et al. Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN colour-and-resect the pancreas study. Surg Endosc. 2017;31(11):4478–84.

PubMed  Google Scholar 

Wei K, Zheng Q, Cheng L, li W, Nießen A, Uzunoglu FG, et al. Minimally invasive versus open surgery for non-functioning pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Int J Surg. 2024. https://doi.org/10.1097/JS9.0000000000002143.

Article  PubMed  PubMed Central  Google Scholar 

Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of pancreatic surgery (ISGPS). Surgery. 2014;155(6):977–88.

PubMed  Google Scholar 

Hackert T, Klaiber U, Pausch T, Mihaljevic AL, Büchler MW. Fifty years of surgery for pancreatic Cancer. Pancreas. 2020;49(8):1005–13.

PubMed  Google Scholar

Comments (0)

No login
gif